No photo of Thomas Baddeley

Thomas Baddeley


    • AB24 3UE

    • 125 Citations
    If you made any changes in Pure these will be visible here soon.

    Fingerprint Dive into the research topics where Thomas Baddeley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 7 Similar Profiles
    Phenylhydrazines Chemical Compounds
    Crystal structure Chemical Compounds
    Hydrogen bonds Chemical Compounds
    Alzheimer Disease Medicine & Life Sciences
    Synucleins Medicine & Life Sciences
    Computational chemistry Chemical Compounds
    computational chemistry Physics & Astronomy
    Sharks Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 2001 2019

    • 125 Citations
    • 23 Article
    • 3 Patent
    Open Access
    Computational chemistry
    computational chemistry
    Surface analysis
    Crystal structure
    1 Citation (Scopus)

    Synthesis, potent anti-TB activity against M. tuberculosis ATTC 27294, crystal structures and complex formation of selected 2-arylidenehydrazinylbenzothiazole derivatives

    Pinheiro, A. C., de Souza, M. V. N., Lourenco, M. C. S., da Costa, C. F., Baddeley, T. C., Low, J. N., Wardell, S. M. S. V. & Wardell, J. L., 15 Feb 2019, In : Journal of Molecular Structure. 1178, p. 655-668 14 p.

    Research output: Contribution to journalArticle

    1 Citation (Scopus)
    11 Downloads (Pure)
    Open Access
    Transgenic Mice
    Parkinson Disease
    Endopeptidase K
    1 Citation (Scopus)
    Hydrogen Bonding
    Hydrogen bonds
    Crystal structure
    2 Citations (Scopus)
    8 Downloads (Pure)

    Cysteine-independent inhibition of Alzheimer's disease-like paired helical filament assembly by leuco-methylthioninium (LMT)

    Al-Hilaly, Y. K., Pollack, S. J., Rickard, J. E., Simpson, M., Raulin, A-C., Baddeley, T., Schellenberger, P., Storey, J. M. D., Harrington, C. R., Wischik, C. M. & Serpell, L. C., 19 Oct 2018, In : Journal of Molecular Biology. 430, 21, p. 4119-4131 13 p.

    Research output: Contribution to journalArticle

    Open Access
    Alzheimer Disease
    tau Proteins
    Neurofibrillary Tangles


    Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease

    Claude Michel Wischik (Participant), Charles Robert Harrington (Participant), John Mervyn David Storey (Participant), Janet Elizabeth Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven John Kemp (Participant), James Peter Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant), C Marshall (Participant)

    Impact: Quality of life Impacts, Economic Impacts